CIM Center for Molecular Immunology - CIM

CIMAvax- EGF ®

categoriaProducto: Commercials

modalidad: Therapeutic Vaccines

producidoPor: CIM

CHEMICAL CONJUGATED FROM RECOMBINANT AND HUMAN EPIDERMAL GROWTH FACTOR COUPLED TO rP64K RECOMBINANT PROTEIN

images/Content/lineaProductos/16962520-0fde-4839-91a0-024fe7b27237.jpg

nombreComercial: CIMAvax- EGF®

formaFarmaceutica: Injectable emulsion for intramuscular use (IM).

propiedadesFarmacologicas: CIMAVAX-EGF® induces an immune response specifi c to the epidermal growth factor (EGF) generated by the self-patient, which inhibits the binding to its receptor (EGFR). Therefore, they inactivate the mechanisms of cell proliferation in tumor cells, dependent on this EGF / EGFR system. CIMAvax- EGF® contains recombinant human EGF conjugated with a transport protein rP64K and emulsifi ed with the adjuvant Montanide ISA 51 VG. The good tolerability and absence of immunotoxicity of CIMAvax- EGF® makes it an attractive treatment both as monotherapy as part of combination strategy; aimed at transforming advanced NSCLC into a chronic disease with improvement survival.

indicacionesTerapeuticas: Advanced non-small cell lung cancer (NSCLC) patients, stage IIIb/IV after fi rst line chemotherapy platinum based as switch maintenance and EGF concentration basal serum more than 780 pg/mL.

aprobacionesEspecialesComercializacion: Cuba: Register No. B-08-063-L03

telefono
Phone Board:
53-7-2717933
General Direction:
53-7-2714335
pin
216th Street corner at 15, Atabey, Playa, Havana, Cuba.
pin
Postal Code:
11 600
Post Office Box:
16 040

Frequent Questions

How can I access the therapeutic vaccines against lung cancer?


Cuba has 2 therapeutic vaccines for advanced lung cancer:
CIMAvax EGF ® and VAXIRA ® (racotumomab). Both therapeutic vaccines have sanitary registration in the indication of stage III and IV advanced non-small cell lung cancer (NSCLC), after the first line of chemotherapy. The main clinical benefit of these vaccines has been shown to be increased survival and improved quality of life, as well as a broad safety profile.

How to acquire the vaccines?
Foreigners should contact the Cuban Medical Services who will evaluate each case as part of a comprehensive patient care program, with commercial value.

-Cuban Medical Services. Web page:
www.smcsalud.cu.; E-mail: smc@smcsalud.cu
Phone: (537) 209-0977 Fax: (537) 203-1590.

You can also make your request for care expressing the reason for your request, a medical summary and personal data directly to:

International Clinic of the Hermanos Ameijeiras Hospital.
Calle San Lázaro # 701 esq. to Belascoaín, Havana Center, Havana, C.P: 10400, Cuba.
Telephone: (537) 8761029, (537) 8761030, (537) 8761683. Email: turismomedico@hha.sld.cu

International Health Center
La Pradera Calle 15 between 222 A and 234, Siboney neighborhood, Playa Municipality, Havana, Cuba
Telephone: (+537) 273 7467 Ext. 403 (+537) 2737202. Email: comercia@cislapradera.cu

More frequently asked questions

Pharmacovigilance

We ensure the quality, safety and effectiveness of our medicines.
We offer information on the use of our products to patients, families and professionals.
Your contribution is very important..
Report suspected adverse reactions here:

Error
Error
Error
Error
Error
Error
Error
captcha